OCLClinical Trials•globenewswire•
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Sentiment:Negative (30)
Summary
(OCL) ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 1, 2025 by globenewswire